Proton beam therapy and iris neovascularisation in uveal melanoma

被引:16
|
作者
Boyd, S. R.
Gittos, A.
Richter, M.
Hungerford, J. L.
Errington, R. D.
Cree, I. A. [1 ]
机构
[1] Alexandra Hosp, Translat Oncol Res Ctr, Dept Histopathol, Michael Darmady Lab, Portsmouth PO6 3LY, Hants, England
[2] UCL, Dept Pathol, Inst Ophthalmol, London, England
[3] Univ Toronto, Dept Ophthalmol, St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[4] Univ Toronto, Vasc Biol Res Grp, St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[5] Moorfields Eye Hosp, London, England
[6] Univ Med Berlin, Ophthalm Clin, Berlin, Germany
[7] Clatterbridge Ctr Oncol, Wirral, Merseyside, England
关键词
iris; angiogenesis; glaucoma; melanoma; proton; irradiation;
D O I
10.1038/sj.eye.6702072
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose Local treatment of uveal melanoma by radiotherapy involves the use of brachytherapy with radioactive plaques attached to the sclera, or proton irradiation. Both treatments induce growth arrest within the tumour and its slow involution over several years. Although ocular retention rates are excellent, regrowth of tumours due to resistance and neovascular glaucoma leads to enucleation of up to 10% of affected eyes. Proton irradiation involves part of the iris in most cases and we noticed that neovascularisation only occurred in the part of the iris that was not irradiated. We therefore conducted this study to determine the relationship between the development of iris neovascularisation and iris irradiation. Methods A total of 21 enucleation specimens from patients who had previously had proton irradiation were collected from the files of the Department of Pathology, Moorfields Eye Hospital during the 5-year period from 1994 to 1999. Sections of these eyes were assessed for VEGF-A, bFGF, and von Willebrand Factor (vWF) by immunohistochemistry. Ophthalmic notes and radiotherapy records were reviewed to assess the extent of iris irradiation. Results In all, 11 cases showed clinical evidence of iris neovascularisation and were selected for further study. Three of these eyes also showed clinical evidence of regrowth of the tumour. Histological evidence of iris neovascularization was noted in all 11 of the eyes examined, and was only present in the nonirradiated side of the iris in 8/11 eyes. NVI was present on both sides of the iris in three cases, but was less severe in the irradiated part. Expression of VEGF-A was at most weak within the tumour, but was present in the detached retina and in the epithelium of both ciliary body and iris. Some bFGF staining was noted around vessels in the iris stroma. Conclusions Our results suggest that irradiation leads to iris atrophy, and that atrophic, irradiated iris is resistant to the development of neovascularisation.
引用
收藏
页码:832 / 836
页数:5
相关论文
共 50 条
  • [41] Gantry-based pencil beam scanning proton therapy for uveal melanoma: IMPT versus proton arc therapy
    Qi, Hang
    Hu, Lei
    Huang, Sheng
    Lee, Yen-Po
    Yu, Francis
    Chen, Qing
    Yang, Yunjie
    Kang, Minglei
    Zhai, Huifang
    Vermeulen, Milo
    Shim, Andy
    Park, Peter
    Ding, Xuanfeng
    Zhou, Jun
    Abramson, David H.
    Francis, Jasmine H.
    Simone, Charles B.
    Barker, Christopher A.
    Lin, Haibo
    RADIATION ONCOLOGY, 2025, 20 (01)
  • [42] Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy
    Newhauser, Wayne D.
    Koch, Nicholas C.
    Fontenot, Jonas D.
    Rosenthal, Stanley J.
    Gombos, Dan S.
    Fitzek, Markus M.
    Mohan, Radhe
    PHYSICS IN MEDICINE AND BIOLOGY, 2007, 52 (13): : 3979 - 3990
  • [43] Proton beam therapy for iris melanomas
    Lumbroso-Le Rouic, L.
    Delacroix, S.
    Dendale, R.
    Levy-Gabriel, C.
    Feuvret, L.
    Noel, G.
    Plancher, C.
    Nauraye, C.
    Garcia, P.
    Calugaru, V.
    Asselain, B.
    Desjardins, L.
    EYE, 2006, 20 (11) : 1300 - 1305
  • [44] Iris colour and uveal melanoma
    Saornil, MA
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2004, 39 (04): : 448 - 452
  • [45] PROTON-BEAM THERAPY OF UVEAL MELANOMAS
    GRAGOUDAS, ES
    ARCHIVES OF OPHTHALMOLOGY, 1986, 104 (03) : 349 - 351
  • [46] Proton beam radiotherapy for uveal melanoma: Results of curie institut-orsay proton therapy center (ICPO)
    Dendale, Remi
    Lumbroso-Le Rouic, Livia
    Noel, Georges
    Feuvret, Loic
    Levy, Christine
    Delacroix, Sabine
    Meyer, Anne
    Nauraye, Catherine
    Mazal, Alejandro
    Mammar, Hamid
    Garcia, Paul
    D'Hermies, Francois
    Frau, Eric
    Plancher, Corine
    Asselain, Bernard
    Schlienger, Pierre
    Mazeron, Jean Jacques
    Desjardins, Laurence
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03): : 780 - 787
  • [47] Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study
    Peyrichon, M. L.
    Vidal, M.
    Barnel, C.
    Sauerwein, W.
    Carnicer, A.
    Angellier, G.
    Mathis, T. M.
    Mishra, K. K.
    Thariat, J.
    Herault, J.
    Herault, J.
    CANCER RADIOTHERAPIE, 2022, 26 (08): : 1027 - 1033
  • [48] Cyclotrons in cancerology: proton therapy applied to uveal melanoma
    Allouch, H
    PRESSE MEDICALE, 2000, 29 (15): : 841 - +
  • [49] PROTON BEAM RADIOTHERAPY FOR UVEAL MELANOMA: RESULTS IN OUR CENTER
    Mammar, H.
    Caujolle, J. P.
    Herault, J.
    Angellier, G.
    Mandrillon, P.
    Trimaud, R.
    Gerard, J. P.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S227 - S227
  • [50] Management of uveal melanoma with proton beam irradiation: The Leiden perspective
    Luyten, G. P. M.
    Beenakker, J. W. M.
    Jager, M. J.
    Bleeker, J. C.
    Vu, T. H. K.
    Rasch, C. R. N.
    Marinkovic, M.
    ACTA OPHTHALMOLOGICA, 2020, 98 : 12 - 12